Plasma binding, clearance, volume of distribution, half-life
Clearance increases during pregnancy, but is smaller in women; smaller in women than men, but increases during pregnancy; plasma binding is unaffected by sex or pregnancy
Considered to be probe for CYP3A4, not substrate for PGP
No sex difference in clearance following either oral or intramuscular administration; interpretation complicated by differences in intestinal and hepatic CYP3A4 levels
Plasma binding, clearance, volume of distribution, and half-life
Plasma binding is similar among men and women; however, plasma binding increases during pregnancy. Clearance is smaller in women. is similar in both men and women and does not appear to be altered during pregnancy. Half-life is decreased in women compared to men but does not appear to be altered during pregnancy
Clearance following intravenous administration more rapid in women, but oral clearance higher in men than women. Substrate for both CYP3A4 and PGP
Sex differences in hepatic and gut CYP3A4 and PGP lead to complex differences in clearance between men and women. Bioavailability from the gut is greater in women. The greater bioavailability leads to increased systemic exposure in women
Oral clearance is lower in women
*Pregnancy-related PK changes are in italics font. Table modified from Soldin and Mattison [5].